## Abstract Breast cancer is a rapidly increasing problem in many developing countries, and cytotoxic chemotherapy is now an integral part of its management. In several developing countries, the carriage of hepatitis B virus (HBV) in cancer patients may be as high as 12%, and such patients are at r
Hepatitis B reactivation in patients receiving cytotoxic chemotherapy: Diagnosis and management
β Scribed by John S Lubel; Peter W Angus
- Book ID
- 108953670
- Publisher
- John Wiley and Sons
- Year
- 2010
- Tongue
- English
- Weight
- 158 KB
- Volume
- 25
- Category
- Article
- ISSN
- 0815-9319
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Hepatitis B virus (HBV) reactivation has been described in cancer patients who received cytotoxic/immunosuppressive therapy and may result in liver damage of varying degrees of severity. There is no known effective treatment. Lamivudine, a nucleoside analogue, has been found to suppress HBV replicat
## Abstract The diagnosis of HBV reactivation during cytotoxic chemotherapy is based on an abrupt rise in levels of serum HBV DNA in conjunction with a hepatitic picture and in the absence of other causes of hepatitis. However, several cases of βhepatitisβ have been noted during chemotherapy in HBs